Strongyloides stercoralis: Risks posed to immigrant patients in an Australian tertiary referral centre

Internal Medicine Journal

Volumn 36, Issue 10, 2006, Pages 632-637

  Einsiedel, L ^a   Spelman, D ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

Hyperinfection; Immigrant; Immunosuppression; Strongyloides

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHYLPREDNISOLONE; PREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ASTHMA; AUSTRALIA; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; ENTERITIS; FECES ANALYSIS; FEMALE; HUMAN; IMMIGRANT; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; MALE; MICROSCOPY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING; SEPSIS; SEROLOGY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AUSTRALIA; EMIGRATION AND IMMIGRATION; FEMALE; HOSPITALS, URBAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TRAVEL;

EID: 33748347712     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01172.x     Document Type: Review

References (18)

1. Grove D. Human strongyloidiasis. Adv Parasitol 1996; 38: 251-309.
2. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insight into the prevention of disseminated disease. Rev Infect Dis 1989; 11: 755-67.
3. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin. Microbiol Rev 2004; 17: 208-17.
4. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 1981; 3: 397-407.
5. Prociv P, Luke R. Observations on strongyloidiasis in Queensland Aboriginal communities. Med J Aust 1993; 158: 160-63.
6. Johnstone FH, Morris PS, Spear R, McCarthy J, Currie B, Ewald D et al. Strongyloidiasis: a review of the evidence for Australian practitioners. Aust J Rural Health 2005; 13: 247-54.
7. Grove DI. Strongyloidiasis in allied ex-prisoners of war in south-east Asia. BMJ 1980; 180: 598-601.
8. De Silva S, Saykao P, Kelly H, Macintyre CR, Ryan N, Leydon J et al. Chronic Strongyloides stercoralis infection in Laotian immigrants and refugees 7-20 years after resettlement in Australia. Epidemiol Infect 2002; 128: 439-44.
9. Sampson IA, Grove DI. Strongyloidiasis is endemic in another Australian population group: Indochinese refugees. Med J Aust 1987; 146: 580-82.
10. Sanchez P, Guzman AP, Guillen SM, Adell RI, Estruch AM, Gonzalo IN et al. Endemic strongyloidiasis on the Spanish Mediterranean coast. QJM 2001; 94: 357-63.
11. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33: 1040-47.
12. Nutman TB, Ottesen EA, Ieng S, Samuels J, Kimball E, Lutkoski M et al. Eosinophilia in Southeast Asian refugees: evaluation at a referral center. J Infect Dis 1987; 155: 309-13.
13. Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 2002; 66: 749-52.
14. Sudarshi S, Stumpfle R, Armstrong M, Ellman T, Parton S, Krishnan P et al. Clinical presentation and diagnostic sensitivity of laboratory tests for Strongyloides stercoralis in travellers compared with immigrants in a non-endemic country. Trop Med Int Health 2003; 8: 728-32.
15. Schaffel R, Nucci M, Carvalho E, Braga M, Almeida L, Portugal R et al. The value of immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies. Am J Trop Med Hyg 2001; 65: 346-50.
16. Avery RK, Ljungman P. Prophylactic measures in the solid organ recipient before transplantation. Clin Infect Dis 2001; 33(Suppl. 1): S15-S21.
17. Davis JS, Currie BJ, Fisher DA, Huffam SE, Anstey NM, Price PN et al. Prevention of opportunistic infections in immunocompromised patients in the tropical top end of the Northern Territory. Commun Dis Intell 2003; 27: 526-32.
18. Kobayashi J, Sato Y, Toma H, Takara M, Shiroma Y. Application of enzyme immunoassay for postchemotherapy evaluation of human strongyloidiasis. Diagn Microbiol Infect Dis 1994; 18: 19-23.